APA (7th ed.) Citation

Kolbin, A. S., Vilyum, I. A., Proskurin, M. A., & Balykina, Y. E. (2015). BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD. IRBIS LLC.

Chicago Style (17th ed.) Citation

Kolbin, A. S., I. A. Vilyum, M. A. Proskurin, and Yu. E. Balykina. BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD. IRBIS LLC, 2015.

MLA (9th ed.) Citation

Kolbin, A. S., et al. BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD. IRBIS LLC, 2015.